Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection

Alzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment...

Full description

Bibliographic Details
Main Authors: Jutamas Jiaranaikulwanitch, Hataichanok Pandith, Sarin Tadtong, Phanit Thammarat, Supat Jiranusornkul, Nattapong Chauthong, Supitcha Nilkosol, Opa Vajragupta
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/6/1562
_version_ 1797541622286647296
author Jutamas Jiaranaikulwanitch
Hataichanok Pandith
Sarin Tadtong
Phanit Thammarat
Supat Jiranusornkul
Nattapong Chauthong
Supitcha Nilkosol
Opa Vajragupta
author_facet Jutamas Jiaranaikulwanitch
Hataichanok Pandith
Sarin Tadtong
Phanit Thammarat
Supat Jiranusornkul
Nattapong Chauthong
Supitcha Nilkosol
Opa Vajragupta
author_sort Jutamas Jiaranaikulwanitch
collection DOAJ
description Alzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment. However, these drugs can only alleviate AD symptoms. Thus, this research focuses on the discovery of novel lead compounds that possess multitarget regulation of AD etiopathology relating to amyloid cascade. The ascorbic acid structure has been designated as a core functional domain due to several characteristics, including antioxidant activities, amyloid aggregation inhibition, and the ability to be transported to the brain and neurons. Multifunctional ascorbic derivatives were synthesized by copper (I)-catalyzed azide–alkyne cycloaddition reaction (click chemistry). The in vitro and cell-based assays showed that compounds <b>2c</b> and <b>5c</b> exhibited prominent multifunctional activities as beta-secretase 1 inhibitors, amyloid aggregation inhibitors, and antioxidant, neuroprotectant, and anti-inflammatory agents. Significant changes in activities promoting neuroprotection and anti-inflammation were observed at a considerably low concentration at a nanomolar level. Moreover, an in silico study showed that compounds <b>2c</b> and <b>5c</b> were capable of being permeated across the blood–brain barrier by sodium-dependent vitamin C transporter-2.
first_indexed 2024-03-10T13:18:35Z
format Article
id doaj.art-a3936d1f81aa4949939a94561b8c76c8
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T13:18:35Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-a3936d1f81aa4949939a94561b8c76c82023-11-21T10:13:30ZengMDPI AGMolecules1420-30492021-03-01266156210.3390/molecules26061562Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and NeuroprotectionJutamas Jiaranaikulwanitch0Hataichanok Pandith1Sarin Tadtong2Phanit Thammarat3Supat Jiranusornkul4Nattapong Chauthong5Supitcha Nilkosol6Opa Vajragupta7Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Pharmacognosy, Faculty of Pharmacy, Srinakharinwirot University, Nakhonnayok 26120, ThailandDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, ThailandOffice of Research Affairs, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandAlzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment. However, these drugs can only alleviate AD symptoms. Thus, this research focuses on the discovery of novel lead compounds that possess multitarget regulation of AD etiopathology relating to amyloid cascade. The ascorbic acid structure has been designated as a core functional domain due to several characteristics, including antioxidant activities, amyloid aggregation inhibition, and the ability to be transported to the brain and neurons. Multifunctional ascorbic derivatives were synthesized by copper (I)-catalyzed azide–alkyne cycloaddition reaction (click chemistry). The in vitro and cell-based assays showed that compounds <b>2c</b> and <b>5c</b> exhibited prominent multifunctional activities as beta-secretase 1 inhibitors, amyloid aggregation inhibitors, and antioxidant, neuroprotectant, and anti-inflammatory agents. Significant changes in activities promoting neuroprotection and anti-inflammation were observed at a considerably low concentration at a nanomolar level. Moreover, an in silico study showed that compounds <b>2c</b> and <b>5c</b> were capable of being permeated across the blood–brain barrier by sodium-dependent vitamin C transporter-2.https://www.mdpi.com/1420-3049/26/6/1562ascorbic derivativesBACE1 inhibitoramyloid aggregation inhibitionantioxidantneuroprotectiveanti-inflammation
spellingShingle Jutamas Jiaranaikulwanitch
Hataichanok Pandith
Sarin Tadtong
Phanit Thammarat
Supat Jiranusornkul
Nattapong Chauthong
Supitcha Nilkosol
Opa Vajragupta
Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
Molecules
ascorbic derivatives
BACE1 inhibitor
amyloid aggregation inhibition
antioxidant
neuroprotective
anti-inflammation
title Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
title_full Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
title_fullStr Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
title_full_unstemmed Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
title_short Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
title_sort novel multifunctional ascorbic triazole derivatives for amyloidogenic pathway inhibition anti inflammation and neuroprotection
topic ascorbic derivatives
BACE1 inhibitor
amyloid aggregation inhibition
antioxidant
neuroprotective
anti-inflammation
url https://www.mdpi.com/1420-3049/26/6/1562
work_keys_str_mv AT jutamasjiaranaikulwanitch novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT hataichanokpandith novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT sarintadtong novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT phanitthammarat novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT supatjiranusornkul novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT nattapongchauthong novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT supitchanilkosol novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection
AT opavajragupta novelmultifunctionalascorbictriazolederivativesforamyloidogenicpathwayinhibitionantiinflammationandneuroprotection